VEGFB186 gene transfer

VEGFB186 gene transfer has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 21, 2025: “Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart”.

Intervention

1 paper studies it6 findingsUpdated

See all 1 papers on VEGFB186 gene transfer

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Deutsche Forschungsgemeinschaft and others
  • Animals1

What did studies of VEGFB186 gene transfer find?

6

Studies of VEGFB186 gene transfer measured 6 outcomes, among them cardiomyocyte length-to-width ratio, cardiac hypertrophy and heart rate variability.

Cardiomyocyte length-to-width ratio

downin mice1

1 study
  1. VEGFB186 gene transfer decreases cardiomyocyte length-to-width ratio in aged hearts.

    “Vegfb186 overexpression corrected the elevated cardiomyocyte length-to-width ratio observed in aged hearts”

    Animalsin aged heartsAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

Cardiac hypertrophy

upin mice1

1 study
  1. VEGFB186 gene transfer increases cardiac hypertrophy in aged hearts, described as compensatory rather than pathological.

    “Although Vegfb186 overexpression induced cardiac hypertrophy”

    Animalsin aged hearts, described as compensatory rather than pathologicalAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

More on Cardiac hypertrophy

Heart rate variability

upin mice1

1 study
  1. VEGFB186 gene transfer increases heart rate variability in aged hearts.

    “Vegfb186 treatment additionally restored sympathetic and sensory nerve fibre density and increased heart rate variability”

    Animalsin aged heartsAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

Sympathetic and sensory nerve fibre density

upin mice1

1 study
  1. VEGFB186 gene transfer increases sympathetic and sensory nerve fibre density in aged hearts.

    “Vegfb186 treatment additionally restored sympathetic and sensory nerve fibre density”

    Animalsin aged heartsAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

Cardiac fibrosis

downin mice1

1 study
  1. VEGFB186 gene transfer prevents cardiac fibrosis in mice (age-induced, in aged hearts after AAV9 delivery).

    “doses of Vegfb186 overexpression that had only a modest effect on the vascular endothelium prevented age-induced diastolic dysfunction and fibrosis”

    Animalsage-induced, in aged hearts after AAV9 deliveryAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

More on Cardiac fibrosis

Diastolic dysfunction

downin mice1

1 study
  1. VEGFB186 gene transfer prevents diastolic dysfunction in mice (age-induced, in aged hearts after AAV9 delivery).

    “doses of Vegfb186 overexpression that had only a modest effect on the vascular endothelium prevented age-induced diastolic dysfunction and fibrosis”

    Animalsage-induced, in aged hearts after AAV9 deliveryAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

More on Diastolic dysfunction

Latest